Pernille Højman Jensen

Title: Pernille Højman Jensen: Innovator in Cancer Treatment

Introduction

Pernille Højman Jensen is a notable inventor based in København S, Denmark. She has made significant contributions to the field of cancer treatment through her innovative research and patents. Her work focuses on therapeutic applications that utilize calcium electroporation to induce tumor necrosis effectively.

Latest Patents

Pernille holds a patent titled "Therapeutic applications of calcium electroporation to effectively induce tumor necrosis." This patent demonstrates that electroporation with calcium ions is efficient on cutaneous and subcutaneous nodules. The inventors disclose that a solution comprising calcium ions (Ca) with a concentration of at least 0.1 M is extremely useful in treating neoplasms, such as cancer. The method involves causing transient permeabilization of the cell membranes of at least part of the neoplasm before, during, and/or after the administration of the solution, which is administered at a ratio of 0.2 to 0.8 of the volume of the neoplasm.

Career Highlights

Pernille is associated with Herlev Hospital, where she continues her research and development in the medical field. Her dedication to improving cancer treatment through innovative methods has positioned her as a key figure in her area of expertise.

Collaborations

Pernille has collaborated with notable colleagues, including Karen Julie Gehl and Stine Krog Frandsen. Their combined efforts contribute to advancing research in therapeutic applications for cancer treatment.

Conclusion

Pernille Højman Jensen's work exemplifies the intersection of innovation and healthcare, particularly in cancer treatment. Her patent on calcium electroporation showcases her commitment to finding effective solutions for challenging medical conditions.